Valuation: Terumo Corporation

Market Cap 3,469B 22.02B 19.56B 18.29B 16.67B 31.38B 2,121B 31.82B 221B 85.67B 1,080B 82.69B 80.9B P/E 2027 *
18.2x
P/E 2028 * 18x
Enterprise Value 3,515B 22.32B 19.82B 18.54B 16.89B 31.8B 2,149B 32.24B 224B 86.81B 1,094B 83.79B 81.97B EV / Sales 2027 *
2.79x
EV / Sales 2028 * 2.57x
Free-Float
97.34%
Yield 2027 *
1.57%
Yield 2028 * 1.7%
1 day-4.59%
1 week-2.31%
Current month-2.33%
1 month-9.13%
3 months+1.31%
6 months+3.63%
Current year-1.17%
1 week 2,243.5
Extreme 2243.5
2,361.5
1 month 2,194.5
Extreme 2194.5
2,488.5
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-4.59%-2.31%-5.95%+14.96% 22.02B
-2.17%-4.33%-27.56%-0.17% 167B
+0.17%-2.34%-8.83%+10.31% 111B
-0.88%+1.19%-25.04%-0.11% 105B
+0.76%+1.25%-48.00%-10.97% 74.82B
+3.17%-0.03%-0.64%+72.13% 59.11B
-0.86%+2.96%+13.57%+59.50% 51.8B
-0.52%-0.65%-6.74%-31.12% 48.5B
-0.85%+0.85%-16.51%+18.41% 40.79B
-0.07%-1.42%+30.49%-7.58% 32.54B
Average -0.25%+0.20%-9.52%+12.54% 71.22B
Weighted average by Cap. +0.20%-0.78%-15.83%+9.76%

Financials

2027 *2028 *
Net sales 1,261B 8B 7.11B 6.65B 6.06B 11.41B 771B 11.56B 80.43B 31.13B 392B 30.05B 29.4B 1,342B 8.52B 7.57B 7.08B 6.45B 12.14B 820B 12.31B 85.6B 33.13B 418B 31.98B 31.29B
Net income 191B 1.21B 1.07B 1B 916M 1.72B 116B 1.75B 12.16B 4.71B 59.31B 4.54B 4.44B 193B 1.22B 1.09B 1.02B 926M 1.74B 118B 1.77B 12.3B 4.76B 60.02B 4.6B 4.5B
Net Debt 45.99B 292M 259M 243M 221M 416M 28.12B 422M 2.93B 1.14B 14.32B 1.1B 1.07B -26.39B -168M -149M -139M -127M -239M -16.14B -242M -1.68B -652M -8.22B -629M -616M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
02/10/26 ¥2,243.50 -4.59% 6,653,200
01/10/26 ¥2,351.50 +2.37% 6,566,900
30/09/26 ¥2,297.00 +0.86% 6,905,000
29/09/26 ¥2,277.50 -0.52% 4,840,400
28/09/26 ¥2,289.50 -0.30% 5,905,500
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,351.50JPY
Average target price
3,110.00JPY
Spread / Average Target
+32.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock